Chiba, Japan

Issei Achiwa




Average Co-Inventor Count = 10.8

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Tokyo, JP (2010)
  • Chiba, JP (2013 - 2015)

Company Filing History:


Years Active: 2010-2015

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Issei Achiwa: Innovator in Antibiotic Development

Introduction

Issei Achiwa is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel antibiotics. With a total of 3 patents to his name, Achiwa's work focuses on creating compounds with unique mechanisms of action.

Latest Patents

Achiwa's latest patents include the development of imidazole carbonyl compounds aimed at creating antibiotics with a novel mechanism of action. These compounds are characterized by weak cytotoxicity, high solubility in water, and the ability to inhibit both DNA gyrase GyrB and topoisomerase IV ParE subunits. The invention provides a pharmaceutical composition that serves as a preventive or therapeutic solution for infectious diseases, showcasing the potential of these compounds as effective antibacterial agents.

Career Highlights

Issei Achiwa is currently associated with Daiichi Sankyo Company, Limited, where he continues to innovate in the pharmaceutical sector. His research has led to advancements in antibiotic development, addressing critical needs in healthcare.

Collaborations

Achiwa has collaborated with notable colleagues such as Hiroshi Takeshita and Junichi Kuroyanagi. Their combined expertise has contributed to the successful development of new pharmaceutical compounds.

Conclusion

Issei Achiwa's work in antibiotic development exemplifies the importance of innovation in addressing healthcare challenges. His contributions are paving the way for new treatments that could significantly impact patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…